A drug with the SMILES Cc1cc(C)n(CCN(C)C(=O)C2CCC(=O)N(CCN3CCOCC3)C2)n1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 9.462%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1cc(C)n(CCN(C)C(=O)C2CCC(=O)N(CCN3CCOCC3)C2)n1
Cc1cc(C)n(CCN(C)C(=O)C2CCC(=O)N(CCN3CCOCC3)C2)n1
N-[2-(3,5-dimethylpyrazol-1-yl)ethyl]-N-methyl-1-(2-morpholin-4-ylethyl)-6-oxopiperidine-3-carboxamide